Enzo Biochem, Inc.
ENZB
$0.5299
-$0.01-1.85%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.40M | 7.33M | 6.21M | 7.53M | 8.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.40M | 7.33M | 6.21M | 7.53M | 8.02M |
| Cost of Revenue | 3.92M | 3.55M | 3.93M | 4.31M | 4.29M |
| Gross Profit | 2.48M | 3.79M | 2.28M | 3.22M | 3.73M |
| SG&A Expenses | 5.37M | 4.91M | 5.34M | 5.28M | 5.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.79M | 8.94M | 9.84M | 10.19M | 10.07M |
| Operating Income | -3.39M | -1.60M | -3.62M | -2.67M | -2.04M |
| Income Before Tax | -2.37M | -1.25M | -3.07M | -1.15M | -2.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.37M | -1.25M | -3.07M | -1.15M | -2.13M |
| Earnings from Discontinued Operations | -416.00K | -287.00K | -305.00K | -12.23M | -889.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.79M | -1.54M | -3.38M | -13.38M | -3.02M |
| EBIT | -3.39M | -1.60M | -3.62M | -2.67M | -2.04M |
| EBITDA | -3.07M | -1.28M | -3.30M | -2.27M | -1.71M |
| EPS Basic | -0.05 | -0.03 | -0.06 | -0.26 | -0.06 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.04 | -0.01 | -0.03 |
| EPS Diluted | -0.05 | -0.03 | -0.07 | -0.26 | -0.06 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.04 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 52.40M | 52.30M | 52.24M | 50.90M | 51.21M |
| Average Diluted Shares Outstanding | 52.40M | 52.30M | 52.24M | 50.90M | 51.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -346.84% | -- | -- | -- |